| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
|
Byrd, John C.
|
|
|
135 |
15 |
p. 1204-1213
|
article
|
| 2 |
Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus–induced sepsis in mice
|
Carestia, Agostina
|
|
|
135 |
15 |
p. 1281-1286
|
article
|
| 3 |
Acetylsalicylic acid to fight thrombosis in sepsis
|
Ho-Tin-Noé, Benoit
|
|
|
135 |
15 |
p. 1195-1196
|
article
|
| 4 |
A few steps on the long road toward biomarkers in GVHD
|
Wolff, Daniel
|
|
|
135 |
15 |
p. 1196-1197
|
article
|
| 5 |
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|
Pillarisetti, Kodandaram
|
|
|
135 |
15 |
p. 1232-1243
|
article
|
| 6 |
Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study
|
Mir, Farheen
|
|
|
135 |
15 |
p. 1214-1218
|
article
|
| 7 |
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression
|
Tissino, Erika
|
|
|
135 |
15 |
p. 1244-1254
|
article
|
| 8 |
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs
|
Six, Emmanuelle
|
|
|
135 |
15 |
p. 1219-1231
|
article
|
| 9 |
Diagnostic bone marrow biopsy in patients with stage I EMZL treated with radiation therapy: needed or not?
|
Alderuccio, Juan Pablo
|
|
|
135 |
15 |
p. 1299-1302
|
article
|
| 10 |
Editorial Board
|
|
|
|
135 |
15 |
p. i
|
article
|
| 11 |
HIT: still stringing us along
|
Warkentin, Theodore E.
|
|
|
135 |
15 |
p. 1193-1194
|
article
|
| 12 |
Hotter is not more aggressive: baseline SUVmax in FL
|
Mikhaeel, N. George
|
|
|
135 |
15 |
p. 1191-1192
|
article
|
| 13 |
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies
|
Schultz, Kirk R.
|
|
|
135 |
15 |
p. 1287-1298
|
article
|
| 14 |
Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors
|
Saenz, Dyana T.
|
|
|
135 |
15 |
p. 1255-1269
|
article
|
| 15 |
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation
|
Johnston, Ian
|
|
|
135 |
15 |
p. 1270-1280
|
article
|
| 16 |
The evolution of viral integration site analysis
|
Radtke, Stefan
|
|
|
135 |
15 |
p. 1192-1193
|
article
|
| 17 |
The fertile field of “isomopic” immune dysregulation as a nidus for lymphoproliferative disorders
|
Hsu, Andrew
|
|
|
135 |
15 |
p. 1303
|
article
|
| 18 |
The TEMPI syndrome
|
Sykes, David B.
|
|
|
135 |
15 |
p. 1199-1203
|
article
|
Journal description